Jul 8, 2025· Comment from Advanced Medical Technology Association (AdvaMed)· FDA-2024-D-3863-0178
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2024-D-3863
Recommendations to Reduce the Risk of Transmission of Mycobacterium Tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry; Availability
RIN
—
Last modified
Jul 8, 2025
Comment window
closed 386d ago
Advanced Medical Technology Association filings
1
Activity
Advanced Medical Technology Association filed 1 comment on this docket between Jul 8, 2025 and Jul 8, 2025. 0 other organizations filed here. The comment window closed 386d ago.
What Advanced Medical Technology Association filed (1)
Abstract
Open
View on regulations.gov →Co-filers (0)
See everyone who commented →- Advanced Medical Technology AssociationTHIS ORG1 filing · confidence 97%